|
|
【NEXGRAM 0096 交流专区】（前名 NEXTNAT）
[复制链接]
|
|
|
发表于 19-7-2019 03:03 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Apr 2019 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Apr 2019 | 30 Apr 2018 | 30 Apr 2019 | 30 Apr 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 15,674 | 11,472 | 42,326 | 32,392 | | 2 | Profit/(loss) before tax | 1,485 | -10,224 | 1,319 | -16,465 | | 3 | Profit/(loss) for the period | 1,493 | -3,031 | 1,357 | -9,226 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 1,785 | -3,012 | 1,074 | -9,244 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.09 | -0.16 | 0.05 | -0.50 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 7.3300 | 7.5600
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 3-9-2019 03:14 AM
|
显示全部楼层
本帖最后由 icy97 于 6-9-2019 07:09 AM 编辑
还2345万债务-nexgram拟发优先股
https://www.enanyang.my/news/20190905/还2345万债务-brnexgram拟发优先股/
Type | Announcement | Subject | MULTIPLE PROPOSALS | Description | NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR THE "COMPANY")(i) PROPOSED SETTLEMENT OF DEBTS OWING TO A DIRECTOR AND SELECTED CREDITORS OF NEXGRAM IN THE AGGREGATE SUM OF RM23,454,664.65 TO BE FULLY SATISFIED THROUGH THE ISSUANCE OF 2,345,466,465 IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES AT AN ISSUE PRICE OF RM0.01 EACH; AND(ii) PROPOSED AMENDMENTS TO THE CONSTITUTION OF NEXGRAM (COLLECTIVELY REFERRED TO AS "PROPOSALS") | On behalf of the Board of Directors of Nexgram, TA Securities Holdings Berhad wishes to announce that the Company proposes to undertake the Proposals. Please refer to the attachment for further details.
This announcement is dated 30 August 2019. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/6272689
|
|
|
|
|
|
|
|
|
|
|
|
发表于 15-10-2019 07:59 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Jul 2019 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Jul 2019 | 31 Jul 2018 | 31 Jul 2019 | 31 Jul 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 16,015 | 13,243 | 58,341 | 45,636 | | 2 | Profit/(loss) before tax | -21,607 | -44,901 | -20,288 | -61,366 | | 3 | Profit/(loss) for the period | -23,199 | -52,500 | -21,841 | -61,726 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -22,987 | -52,405 | -21,913 | -61,648 | | 5 | Basic earnings/(loss) per share (Subunit) | -1.12 | -2.76 | -1.07 | -3.25 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 6.0100 | 7.5600
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 23-3-2020 08:41 AM
|
显示全部楼层
Type | Announcement | Subject | AUDIT REPORT - MODIFIED OPINION / MATERIAL UNCERTAINTY RELATED TO GOING CONCERN
MATERIAL UNCERTAINTY RELATED TO GOING CONCERN | Description | NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR "THE COMPANY")- AUDIT REPORT OF NEXGRAM'S AUDITED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 JULY 2019 - MATERIAL UNCERTAINTY RELATED TO GOING CONCERN | Pursuant to paragraph 9.19(38) of the Ace Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of Nexgram hereby announces that the Company’s independent auditors, Messrs STYL Associates had issued a statement of material uncertainty related to going concern in its independent auditors’ report in respect of Nexgram's Audited Financial Statements for the financial year ended 31 July 2019.
Please refer to the attachment for details.
This announcement is dated 5 December 2019. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3007846
|
|
|
|
|
|
|
|
|
|
|
|
发表于 1-4-2020 07:35 AM
|
显示全部楼层
Date of change | 27 Dec 2019 | Name | DATO' IR LIM SIANG CHAI | Age | 64 | Gender | Male | Nationality | Malaysia | Designation | Chairman | Directorate | Executive | Type of change | Resignation | Reason | Personal Commitment |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 2-4-2020 07:13 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Oct 2019 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Oct 2019 | 31 Oct 2018 | 31 Oct 2019 | 31 Oct 2018 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 12,003 | 11,651 | 12,003 | 11,651 | | 2 | Profit/(loss) before tax | 477 | -624 | 477 | -624 | | 3 | Profit/(loss) for the period | 500 | -587 | 500 | -587 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 67 | -963 | 67 | -963 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.00 | -0.05 | 0.00 | -0.05 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0606 | 0.0605
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 2-4-2020 07:17 AM
|
显示全部楼层
Date of change | 30 Dec 2019 | Name | DATO' SRI RUSLI BIN AHMAD | Age | 62 | Gender | Male | Nationality | Malaysia | Type of change | Redesignation | Previous Position | Independent Director | New Position | Non Executive Chairman | Directorate | Independent and Non Executive |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 19-5-2020 08:03 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Jan 2020 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Jan 2020 | 31 Jan 2019 | 31 Jan 2020 | 31 Jan 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 8,938 | 15,001 | 20,941 | 26,652 | | 2 | Profit/(loss) before tax | -1,572 | 458 | -1,095 | -166 | | 3 | Profit/(loss) for the period | -1,714 | 451 | -1,213 | -136 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -1,638 | 252 | -1,571 | -712 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.08 | 0.01 | -0.08 | -0.04 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0711 | 0.0605
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 28-5-2020 06:07 AM
|
显示全部楼层
本帖最后由 icy97 于 28-5-2020 07:29 AM 编辑
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | STRATEGIC SOURCING AGREEMENT ENTERED INTO BETWEEN NEXGRAM INDUSTRIES SDN BHD WITH PT MITRA ABADI PROPERTINDO UTAMA FOR DISTRIBUTING MEDICAL DEVICES TO INDONESIA AND CERTAIN PART OF SOUTH EAST ASIA MARKET | The Board of Directors of Nexgram is pleased to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 16 April 2020 entered into a Strategic Sourcing Agreement (“Agreement”) with PT Mitra Abadi Propertindo Utama (“MAPU”) to sell to MAPU for the latter to promote, market and distribute Detection and Diagnostic Kit and Rapid Test Kit, and other medical supplies products in Indonesia and certain part of South East Asia market, as per the terms and condition of the Agreement.
Please refer to the attachment for details of the announcement.
This announcement is dated 20 April 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3045166
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | EXCLUSIVE MASTER DISTRIBUTION AGREEMENT ENTERED INTO BY TRI-G TECHNOLOGIES SDN BHD (TRI-G) FOR DISTRIBUTING TRI-G'S COVID-19 MEDICAL DEVICES TO BE UNDERTAKEN BY NEXGRAM INDUSTRIES SDN BHD | Reference is made to the Company’s announcement dated 20 April 2020 in relation to the Strategic Outsourcing Agreement, it was stated therein that Nexgram Industries Sdn. Bhd. (“NISB”), the wholly-owned subsidiary of the Company had on 27 March 2020 appointed as the Exclusive Master Distributor of Tri-G Technologies Sdn. Bhd. (“TRI-G”) to distribute TRI-G’s medical supplies, including quantitative RT-PCR (Reverse Transcription Polymerase Chain Reaction) or RT-qPCR (Quantitative Reverse Transcription PCR) machines, reagents and test kits and Coronavirus test kits in Malaysia for a period of 2 years, commencing 27 March 2020.
In furtherance to that, the Board of Directors of Nexgram wishes to clarify and announce further information in relation to the Exclusive Master Distribution Agreement ("DA") entered into between TRI-G and NISB.
Please refer to the attachment for details of the announcement.
This announcement is dated 21 April 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3045242
|
|
|
|
|
|
|
|
|
|
|
|
发表于 30-5-2020 08:04 AM
|
显示全部楼层
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | STRATEGIC SOURCING AGREEMENT ENTERED INTO BETWEEN NEXGRAM INDUSTRIES SDN BHD WITH PT RAFA TOPAZ UTAMA FOR DISTRIBUTING MEDICAL DEVICES TO JAKARTA TIMUR INDONESIA AND CERTAIN PART OF SOUTH EAST ASIA MARKET | The Board of Directors of Nexgram is pleased to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 21 April 2020 entered into a Strategic Sourcing Agreement (“Agreement”) with PT Rafa Topaz Utama (“RAFA”) to sell to RAFA for the latter to promote, market and distribute medical ventilators in Jakarta Timur, Indonesia and certain part of South East Asia market, as per the terms and condition of the Agreement.
Please refer to the attachment for details of the announcement.
This announcement is dated 22 April 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3045665
|
|
|
|
|
|
|
|
|
|
|
|
发表于 2-6-2020 06:31 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | ACQUISITION OF 51% OF EQUITY IN TRI-G TECHNOLOGIES SDN BHD (TRI-G) BY NEXGRAM INDUSTRIES SDN BHD, A SUBSIDIARY OF THE COMPANY (PROPOSED ACQUISITION) | Pursuant to Rule 10.05 of the Bursa Malaysia Securities Berhad ACE Market Listing Requirements, the Board of Directors of Nexgram wishes to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 28 April 2020 entered into a Share Sales Agreement (“SSA”) with the following Parties, to obtain a combined total of 51% equity interest in Tri-G Technologies Sdn Bhd (“TRI-G”) (Company No. 899363-H) for a total consideration of Ringgit Malaysia Two Million Forty Thousand (RM2,040,000.00) only (“the Acquisition”) via the issuance of Redeemable Convertible Preference Shares (“RCPS”) in NISB.
Please refer to the attachment for details of the announcement.
This announcement is dated 4 May 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3048205
|
|
|
|
|
|
|
|
|
|
|
|
发表于 13-6-2020 05:25 AM
|
显示全部楼层
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | SALES AGREEMENT ENTERED INTO BETWEEN NEXGRAM INDUSTRIES SDN BHD WITH SHANGHAI LIANGRUN BIOMEDICINE TECHNOLOGY CO., LTD FOR DISTRIBUTING TRI-G'S COVID-19 MEDICAL DEVICES AND AS AN AUTHORISED DISTRIBUTOR FOR MALAYSIA | The Board of Directors of Nexgram is pleased to announce that Nexgram Industries Sdn Bhd. (“NISB”), a wholly-owned subsidiary of the Company has on 12 March 2020 entered into a Sales Agreement (“Agreement”) with Shanghai Liangrun Biomedicine Technology Co., Ltd (“Shanghai Liangrun”) to sell their product, Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19 (“Diagnostic Kit”) in Malaysia and Indonesia. Besides, Shanghai Liangrun has directly appointed NISB as the authorised distributor to seek the approvals from the Ministry of Health in Malaysia and relevant authorities in Indonesia for the distribution of the Diagnostic Kit.
Please refer to the attachment for details of the announcement.
This announcement is dated 27 May 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3053418
|
|
|
|
|
|
|
|
|
|
|
|
发表于 31-7-2020 09:15 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | INCORPORATION OF A NEW SUB-SUBSIDIARY UNDER THE COMPANIES ACT 2016 | NEXGRAM HOLDINGS BERHAD (660055-H) INCORPORATION OF A NEW SUB-SUBSIDIARY NEXGRAM BIOMEDIC SDN. BHD.
1. INTRODUCTION Announcement pursuant to Paragraph 9.19(24) of the Ace Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of Nexgram Holdings Berhad (“NEXGRAM” or “the Company”) is pleased to announce that Nexgram had on 2 June 2020 incorporated a sub-subsidiary under the laws of the Companies Act 2016, namely Nexgram Biomedic Sdn. Bhd.(Company No. 1369237-A)(“NEXGRAM BIOMEDIC”).
2. INFORMATION ON NEXGRAM SDN. BHD. NEXGRAM BIOMEDIC was incorporated as a Company Limited by Shares under the laws of Companies Act 2016 with an issued share capital of RM100,000.00 and in the business of general, drug and vaccine research and development, manufacturing, sales and distribution of pharmaceutical products and medical instruments.
The Directors of NEXGRAM BIOMEDIC are as follows:
Directors | Nationality | Haji Mazru Bin Mat Yusof. | Malaysian | | Dato' Yek Siew Lee | Malaysian |
The Shareholder of NEXGRAM BIOMEDIC and its shareholding in NEXGRAM BIOMEDIC is as follows:
Shareholder | Number of Shares | Shareholding (%) | Nexgram Industries Sdn. Bhd. (a wholly owned subsidiary of NEXGRAM) | 10,000,000 ordinary shares | 100% |
3. RATIONALE OF THE INCORPORATION The purpose of incorporation of NEXGRAM BIOMEDIC is to expand NEXGRAM business as in carrying various business activities to generate more revenue.
4. FINANCIAL EFFECT OF THE INCORPORATION The incorporation of NEXGRAM BIOMEDIC will not have any material effect on the share capital and substantial shareholders’ shareholdings of NEXGRAM, and is not expected to have any material effect on the earnings per share, net assets per share and gearing of the Group for the financial year ending 31 July 2020.
5. INTEREST OF DIRECTORS AND/OR SUBSTANTIAL SHAREHOLDERS AND/OR PERSONS CONNECTED TO THEM Save for Haji Mazru Bin Mat Yusof and Dato' Yek Siew Lee, who are the Directors of NEXGRAM and acting as NEXGRAM’s Representatives in NEXGRAM BIOMEDIC, has declared his interest by virtue of the fact that they are the first director in NEXGRAM BIOMEDIC, none of the Directors and/or substantial shareholders of NEXGRAM and/or persons connected with them have any interest direct or indirect, in the above incorporation.
6. STATEMENT BY THE BOARD OF DIRECTORS The Board of Directors of NEXGRAM is of the opinion that the above incorporation is in the best interest of the Company.
This Announcement is dated 5 June 2020.
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-9-2020 09:38 AM
|
显示全部楼层
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | NEXGRAM HOLDINGS BERHAD ("NEXGRAM" OR THE "COMPANY")DISPOSAL OF ONE BLOCK OF 11-STOREY STRATIFIED OFFICE BUILDING, BLOCK 1 (TYPE E), THE HORIZON, BANGSAR SOUTH, KNOWN AS NEXGRAM TOWER, BY COCONUT THREE SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF NEXGRAM, TO IMS DEVELOPMENT SDN BHD FOR A CASH CONSIDERATION OF RM67,000,000 ("DISPOSAL") | We refer to the announcements made on 3 January 2019, 25 March 2019, 30 May 2019, 7 August 2019, 8 August 2019 and 23 August 2019 in relation to the Disposal (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein.
On behalf of the Board, TA Securities wishes to announce that the Disposal has been completed on 25 June 2020 in accordance with the terms and conditions of the SPA.
This announcement is dated 25 June 2020.
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 11-10-2020 08:40 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Apr 2020 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Apr 2020 | 30 Apr 2019 | 30 Apr 2020 | 30 Apr 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 4,497 | 15,674 | 25,438 | 42,326 | | 2 | Profit/(loss) before tax | -1,195 | 1,485 | -2,290 | 1,319 | | 3 | Profit/(loss) for the period | -1,188 | 1,493 | -2,401 | 1,357 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -656 | 1,785 | -2,321 | 1,074 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.03 | 0.09 | -0.11 | 0.05 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0719 | 0.0605
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 26-10-2020 05:36 AM
|
显示全部楼层
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Conversion of Preference Shares | Details of corporate proposal | Conversion of Irredeemable Convertible Preference Shares ("ICPS") to Ordinary Shares | No. of shares issued under this corporate proposal | 140,000,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.0200 | Par Value($$) (if applicable) | Malaysian Ringgit (MYR) 0.000 | | Latest issued share capital after the above corporate proposal in the following | Units | 2,211,204,480 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 225,574,587.650 | Listing Date | 13 Jul 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 1-11-2020 09:16 AM
|
显示全部楼层
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)Particulars of Substantial Securities HolderName | OZURA FIRSTLOGIX SDN BHD | Address | 1-47, Jalan SP2
Taman Segar Perdana
Cheras
43200 Selangor
Malaysia. | Company No. | 877960-P | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | OZURA FIRSTLOGIX SDN BHD | Address of registered holder | 1-47, Jalan SP2Taman Segar Perdana43200 CherasSelangor |
| Date interest acquired & no of securities acquired | Date interest acquired | 13 Jul 2020 | No of securities | 140,000,000 | Circumstances by reason of which Securities Holder has interest | Conversion of Irredeemable Convertible Preference Shares | Nature of interest | Direct Interest |  | | Total no of securities after change | Direct (units) | 140,000,000 | Direct (%) | 6.338 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Date of notice | 13 Jul 2020 | Date notice received by Listed Issuer | 14 Jul 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 3-11-2020 08:23 AM
|
显示全部楼层
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Conversion of Preference Shares | Details of corporate proposal | Conversion of Irredeemable Convertible Preference Shares ("ICPS") to Ordinary Shares | No. of shares issued under this corporate proposal | 150,000,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.0200 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 2,361,204,480 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 227,074,587.650 | Listing Date | 17 Jul 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 5-11-2020 08:22 AM
|
显示全部楼层
Particulars of substantial Securities HolderName | OZURA FIRSTLOGIX SDN BHD | Address | 1-47, Jalan SP2
Taman Segar Perdana
Cheras
43200 Selangor
Malaysia. | Company No. | 877960-P | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares |
Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | | 1 | 17 Jul 2020 | 150,000,000 | Others | Direct Interest | Name of registered holder | Ozure Firstlogix Sdn Bhd | Address of registered holder | 1-47, Jalan SP2 Taman Segar Perdana 43200 Cheras Selangor | Description of "Others" Type of Transaction | Conversion ICPS |
Circumstances by reason of which change has occurred | Conversion of Irredeemable Convertible Preference Shares | Nature of interest | Direct Interest | Direct (units) | 290,000,000 | Direct (%) | 12.295 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 290,000,000 | Date of notice | 17 Jul 2020 | Date notice received by Listed Issuer | 17 Jul 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 11-11-2020 07:53 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | NEXGRAM HOLDINGS BERHAD (NEXGRAM OR THE COMPANY) CONDITIONAL OFFTAKE AND PURCHASE AGREEMENT ENTERED INTO BETWEEN NEXGRAM BIOMEDIC SDN BHD WITH PT MITRA ABADI PROPERTINDO UTAMA FOR DISTRIBUTING PERSONAL PROTECTION EQUIPMENT TO INDONESIA | The Board of Directors of Nexgram is pleased to announce that Nexgram Biomedic Sdn Bhd. (“NBSB”), a wholly-owned sub-subsidiary of the Company entered into a Conditional Offtake and Purchase Agreement (“Agreement”) with PT Mitra Abadi Propertindo Utama (“MAPU”) on 22 July 2020 to sell to MAPU for the latter to promote, market and distribute personal protection equipment (“PPE”) includes gown known as AAMI Isolation Gown and medical glove product known as K-Gloves Nitrile Examination Gloves-powder free in Indonesia, as per the terms and condition of the Agreement.
Please refer to the attachment for details of the announcement.
This announcement is dated 23 July 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3071382
|
|
|
|
|
|
|
|
|
|
| |
 本周最热论坛帖子
|
2704 
107
